Form 4: Equillium CFO Jason Keyes Sells 10,000 Shares Under 10b5-1 Trading Plan

Equillium's Chief Financial Officer, Jason Keyes, sold 10,000 shares of common stock at an average price of $0.81, according to a Form 4 filing with the SEC.

Summary

• Jason A. Keyes, the Chief Financial Officer of Equillium, Inc., reported a transaction involving the sale of Equillium's common stock on September 26, 2024.
• Keyes sold 10,000 shares at a weighted average price of $0.81 per share.
• The sales were executed under a pre-arranged 10b5-1 trading plan adopted on March 27, 2024.
• Following the transaction, Keyes directly owns 73,913 shares and indirectly owns 57,720 shares through The Keyes Trust Dated September 10, 2004.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction was conducted under a pre-arranged trading plan, suggesting it's not necessarily indicative of the CFO's current outlook on the company.

Industry Context

Form 4 filings are a routine part of the regulatory landscape, providing transparency into the trading activities of company insiders. Investors often monitor these filings to gauge management's sentiment and confidence in the company's prospects.

Stakeholder Impact

• The stock sale by a key executive could be perceived negatively by some shareholders, potentially leading to short-term price fluctuations.

Key Dates